Welcome to Reniguard

logoring

Reniguard Life Sciences Inc is a biotech company specialized in the construction, production, purification and analysis of biomolecules (DNA, RNA, protein) and cells, using conventional molecular, cellular, biochemical and immunological tools as well as proprietary technologies.

We function as a contract research organization (CRO) assisting our clients in their clinical biomarker studies and drug discovery & development activities. We also develop clinical diagnostic tests. Our mission is to improve clinical management of various diseases through our scientific research and innovations.

What We Do

Biomarker identification & validation

DNA detection & quantification
DNA mutation detection & quantification
DNA methylation analysis
DNA methylation quantification
DNA isolation
DNA cloning & mutagenesis

RNA purification & characterization
RNA quantification (RT-qPCR)
RNA mutation detection

ELISA, Western blotting
Biochemical assays
Cell-based assays
Custom assay development

Mutation assay kits
       KRas, BRaf, HBV, and more...
       Novel qPCR technologies
       Ultra-sensitive
       Unmatched specificity

Custom mutation assays

Click here for current promotions.

About Us

We strive to provide exceptional customer service to our industrial and academic clients at the very best rates. Our in-depth scientific knowledge, client-focused culture, and GLP quality control system ensure that the projects are completed with attention to details, collaborative and innovative approaches, customer flexibility, and uncompromised quality.

Scientists at Reniguard value scientific excellence and excel at technical innovations. A number of cutting edge PCR technologies, such as ultra-sensitive mutation detection techniques and a unique methylation detection technique, have been developed at Reniguard. Several molecular assays are being developed and evaluated in clinical studies. Our active R&D brings high quality and cutting-edge technologies to our clients.